- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in oral peptide therapeutics
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-18
DOI
10.1038/s41573-019-0053-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthesis of CSK-DEX-PLGA Nanoparticles for the Oral Delivery of Exenatide to Improve Its Mucus Penetration and Intestinal Absorption
- (2019) Yina Song et al. MOLECULAR PHARMACEUTICS
- Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial
- (2019) Inge B Halberg et al. Lancet Diabetes & Endocrinology
- Intestinal Permeation Enhancers for Oral Delivery of Macromolecules: A Comparison between Salcaprozate Sodium (SNAC) and Sodium Caprate (C10)
- (2019) Caroline Twarog et al. Pharmaceutics
- An ingestible self-orienting system for oral delivery of macromolecules
- (2019) Alex Abramson et al. SCIENCE
- Separating host and microbiome contributions to drug pharmacokinetics and toxicity
- (2019) Michael Zimmermann et al. SCIENCE
- Osteoporosis
- (2019) Juliet E Compston et al. LANCET
- A Delivery System for Oral Administration of Proteins/Peptides Through Bile Acid Transport Channels
- (2019) Siwen Wu et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Intestinal iontophoresis from mucoadhesive patches: a strategy for oral delivery
- (2019) Amrita Banerjee et al. JOURNAL OF CONTROLLED RELEASE
- Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea
- (2019) Julio Rosenstock et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Oral Semaglutide on the Pharmacokinetics of Lisinopril, Warfarin, Digoxin, and Metformin in Healthy Subjects
- (2019) Tine A. Bækdal et al. CLINICAL PHARMACOKINETICS
- DIABETIC GASTROPARESIS
- (2019) Adil E Bharucha et al. ENDOCRINE REVIEWS
- 54-OR: Oral Semaglutide vs. Empagliflozin Added On to Metformin Monotherapy in Uncontrolled Type 2 Diabetes: PIONEER 2
- (2019) EDUARD MONTANYA et al. DIABETES
- PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes
- (2019) Vanita R. Aroda et al. DIABETES CARE
- Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial
- (2019) Richard Pratley et al. LANCET
- Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2019) Mansoor Husain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
- (2019) Ofri Mosenzon et al. Lancet Diabetes & Endocrinology
- Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial
- (2019) Bernard Zinman et al. DIABETES CARE
- Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial
- (2019) Helena W. Rodbard et al. DIABETES CARE
- Novel strategy for oral peptide delivery in incretin-based diabetes treatment
- (2019) Yining Xu et al. GUT
- A luminal unfolding microneedle injector for oral delivery of macromolecules
- (2019) Alex Abramson et al. NATURE MEDICINE
- Combination Strategy with Complexation Hydrogels and Cell-Penetrating Peptides for Oral Delivery of Insulin
- (2018) Yu Fukuoka et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects with Renal Impairment
- (2018) Charlotte Granhall et al. CLINICAL PHARMACOKINETICS
- Multiple Oral Insulin (ORMD-0801) Doses Elicit a Cumulative Effect on Glucose Control in T2DM Patients
- (2018) ROY ELDOR et al. DIABETES
- Insulin Access and Affordability Working Group: Conclusions and Recommendations
- (2018) William T. Cefalu et al. DIABETES CARE
- Microparticles, microcapsules and microspheres: A review of recent developments and prospects for oral delivery of insulin
- (2018) Chun Y. Wong et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The use of low molecular weight protamine to enhance oral absorption of exenatide
- (2018) Liping Zhang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Pharmacokinetics, Safety, and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment
- (2018) Tine A. Baekdal et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Increased jejunal permeability in human obesity is revealed by a lipid challenge and is linked to inflammation and type 2 diabetes
- (2018) Laurent Genser et al. JOURNAL OF PATHOLOGY
- Oral delivery of anti-diabetes therapeutics using cell penetrating and transcytosing peptide strategies
- (2018) Sahrish Rehmani et al. PEPTIDES
- Ionic liquids for oral insulin delivery
- (2018) Amrita Banerjee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection
- (2018) Christoph A. Thaiss et al. SCIENCE
- Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial
- (2018) Richard E Pratley et al. Lancet Diabetes & Endocrinology
- Multifunctional Nanoparticles Enable Efficient Oral Delivery of Biomacromolecules via Improving Payload Stability and Regulating the Transcytosis Pathway
- (2018) Yaxian Zheng et al. ACS Applied Materials & Interfaces
- Enterically delivered insulin tregopil exhibits rapid absorption characteristics and a pharmacodynamic effect similar to human insulin in conscious dogs
- (2018) Justin M. Gregory et al. DIABETES OBESITY & METABOLISM
- Oral peptide delivery: Translational challenges due to physiological effects
- (2018) Puneet Tyagi et al. JOURNAL OF CONTROLLED RELEASE
- Impact of Insulin Tregopil and its Permeation Enhancer on Pharmacokinetics of Metformin in Healthy Volunteers: Randomized, Open-label, Placebo Controlled, Crossover Study
- (2018) Anand Khedkar et al. CTS-Clinical and Translational Science
- Long-term oral administration of Exendin-4 to control type 2 diabetes in a rat model
- (2018) Kenichi Suzuki et al. JOURNAL OF CONTROLLED RELEASE
- Non-invasive delivery strategies for biologics
- (2018) Aaron C. Anselmo et al. NATURE REVIEWS DRUG DISCOVERY
- The Activity of Peptides of the Calcitonin Family in Bone
- (2018) Dorit Naot et al. PHYSIOLOGICAL REVIEWS
- Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist
- (2018) Stephen T. Buckley et al. Science Translational Medicine
- Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes
- (2017) Melanie Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Discovery, characterization, and clinical development of the glucagon-like peptides
- (2017) Daniel J. Drucker et al. JOURNAL OF CLINICAL INVESTIGATION
- Rational design of polyarginine nanocapsules intended to help peptides overcoming intestinal barriers
- (2017) Zhigao Niu et al. JOURNAL OF CONTROLLED RELEASE
- Safety and efficacy of self-assembling bubble carriers stabilized with sodium dodecyl sulfate for oral delivery of therapeutic proteins
- (2017) Po-Yen Lin et al. JOURNAL OF CONTROLLED RELEASE
- Oral insulin delivery: existing barriers and current counter-strategies
- (2017) Ahmed Gedawy et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
- (2017) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cell–Cell Junctions Organize Structural and Signaling Networks
- (2017) Miguel A. Garcia et al. Cold Spring Harbor Perspectives in Biology
- Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials
- (2016) T.A.S. Aguirre et al. ADVANCED DRUG DELIVERY REVIEWS
- Intestinal permeation enhancers for oral peptide delivery
- (2016) Sam Maher et al. ADVANCED DRUG DELIVERY REVIEWS
- Oral absorption of peptides and nanoparticles across the human intestine: Opportunities, limitations and studies in human tissues
- (2016) P. Lundquist et al. ADVANCED DRUG DELIVERY REVIEWS
- A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D
- (2016) Kim Henriksen et al. BONE
- Lysosomal solute carrier transporters gain momentum in research
- (2016) B Bissa et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Self-reported Barriers to Adherence and Persistence to Treatment With Injectable Medications for Type 2 Diabetes
- (2016) C. Victor Spain et al. CLINICAL THERAPEUTICS
- Enhancement of oral insulin bioavailability: in vitro and in vivo assessment of nanoporous stimuli-responsive hydrogel microparticles
- (2016) Naveed Ahmad et al. Expert Opinion on Drug Delivery
- Pharmacodynamics and pharmacokinetics of oral salmon calcitonin in the treatment of osteoporosis
- (2016) Leonardo Bandeira et al. Expert Opinion on Drug Metabolism & Toxicology
- Preparation and in vivo evaluation of an orally available enteric-microencapsulated parathyroid hormone (1-34)-deoxycholic acid nanocomplex
- (2016) Jin Woo Park et al. International Journal of Nanomedicine
- Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates
- (2016) Jianyong Sheng et al. JOURNAL OF CONTROLLED RELEASE
- Overcoming the Diffusion Barrier of Mucus and Absorption Barrier of Epithelium by Self-Assembled Nanoparticles for Oral Delivery of Insulin
- (2015) Wei Shan et al. ACS Nano
- Contrasting Effects of Lixisenatide and Liraglutide on Postprandial Glycemic Control, Gastric Emptying, and Safety Parameters in Patients With Type 2 Diabetes on Optimized Insulin Glargine With or Without Metformin: A Randomized, Open-Label Trial
- (2015) Juris J. Meier et al. DIABETES CARE
- Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5
- (2015) John B. Buse et al. DIABETES CARE
- Upper gastrointestinal motility and symptoms in individuals with diabetes, prediabetes and normal glucose tolerance
- (2015) Georgios C. Boronikolos et al. DIABETOLOGIA
- Effective incorporation of insulin in mucus permeating self-nanoemulsifying drug delivery systems
- (2015) Theodora Karamanidou et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Steric and interactive barrier properties of intestinal mucus elucidated by particle diffusion and peptide permeation
- (2015) Marie Boegh et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Safety and Efficacy of Oral Octreotide in Acromegaly: Results of a Multicenter Phase III Trial
- (2015) Shlomo Melmed et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Semaglutide, a once-weekly human GLP-1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel
- (2015) Christoph Kapitza et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Improved oral absorption of exenatide using an original nanoencapsulation and microencapsulation approach
- (2015) Liat Soudry-Kochavi et al. JOURNAL OF CONTROLLED RELEASE
- Intestinal and hepatic drug transporters: pharmacokinetic, pathophysiological, and pharmacogenetic roles
- (2015) Tomohiro Terada et al. JOURNAL OF GASTROENTEROLOGY
- Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
- (2015) Jesper Lau et al. JOURNAL OF MEDICINAL CHEMISTRY
- Analysis of Intra- and Intersubject Variability in Oral Drug Absorption in Human Bioequivalence Studies of 113 Generic Products
- (2015) Masahisa Sugihara et al. MOLECULAR PHARMACEUTICS
- Toward Oral Delivery of Biopharmaceuticals: An Assessment of the Gastrointestinal Stability of 17 Peptide Drugs
- (2015) Jie Wang et al. MOLECULAR PHARMACEUTICS
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Strategic Approaches to Optimizing Peptide ADME Properties
- (2014) Li Di AAPS Journal
- Mucus as a Barrier to Drug Delivery - Understanding and Mimicking the Barrier Properties
- (2014) Marie Boegh et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates
- (2014) Bradley Croy Doak et al. CHEMISTRY & BIOLOGY
- Diabetes Insipidus: Celebrating a Century of Vasopressin Therapy
- (2014) Sana Qureshi et al. ENDOCRINOLOGY
- A Novel Suspension Formulation Enhances Intestinal Absorption of Macromolecules Via Transient and Reversible Transport Mechanisms
- (2014) Shmuel Tuvia et al. PHARMACEUTICAL RESEARCH
- Pharmacokinetics of Oral Recombinant Human Parathyroid Hormone [rhPTH(1–31)NH2] in Postmenopausal Women with Osteoporosis
- (2013) Amy Sturmer et al. CLINICAL PHARMACOKINETICS
- Mucoadhesive intestinal devices for oral delivery of salmon calcitonin
- (2013) Vivek Gupta et al. JOURNAL OF CONTROLLED RELEASE
- Human colonic mucus is a reservoir for antimicrobial peptides
- (2013) Lena Antoni et al. Journal of Crohns & Colitis
- The gastrointestinal mucus system in health and disease
- (2013) Malin E. V. Johansson et al. Nature Reviews Gastroenterology & Hepatology
- Glucose-Reducing Effect of the ORMD-0801 Oral Insulin Preparation in Patients with Uncontrolled Type 1 Diabetes: A Pilot Study
- (2013) Roy Eldor et al. PLoS One
- Mucus Enhances Gut Homeostasis and Oral Tolerance by Delivering Immunoregulatory Signals
- (2013) M. Shan et al. SCIENCE
- Efficacy and safety of recombinant human parathyroid hormone (1–84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study
- (2013) Michael Mannstadt et al. Lancet Diabetes & Endocrinology
- The single dose pharmacokinetic profile of a novel oral human parathyroid hormone formulation in healthy postmenopausal women
- (2012) Sibylle P. Hämmerle et al. BONE
- Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1–31)NH2] in postmenopausal women with osteoporosis
- (2012) K. Henriksen et al. BONE
- Metabolism and disposition of the oral absorption enhancer 14C-radiolabeled 8-(N-2-hydroxy-5-chlorobenzoyl)-amino-caprylic acid (5-CNAC) in healthy postmenopausal women and supplementary investigations in vitro
- (2012) Hans-Peter Gschwind et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Paracellular drug absorption enhancement through tight junction modulation
- (2012) Hendrik JR Lemmer et al. Expert Opinion on Drug Delivery
- A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: The oral calcitonin in postmenopausal osteoporosis (ORACAL) trial
- (2012) Neil Binkley et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Oral Octreotide Absorption in Human Subjects: Comparable Pharmacokinetics to Parenteral Octreotide and Effective Growth Hormone Suppression
- (2012) S. Tuvia et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
- (2011) Laura M. Ensign et al. ADVANCED DRUG DELIVERY REVIEWS
- Zonula occludens-1 and -2 regulate apical cell structure and the zonula adherens cytoskeleton in polarized epithelia
- (2011) Alan S. Fanning et al. MOLECULAR BIOLOGY OF THE CELL
- A dose range finding study of novel oral insulin (IN-105) under fed conditions in type 2 diabetes mellitus subjects
- (2010) A. Khedkar et al. DIABETES OBESITY & METABOLISM
- Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an Fc fusion protein
- (2010) Wolfgang Glaesner et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Liraglutide
- (2010) Daniel J. Drucker et al. NATURE REVIEWS DRUG DISCOVERY
- Intestinal barrier function: Molecular regulation and disease pathogenesis
- (2009) Katherine R. Groschwitz et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Discovery of synergistic permeation enhancers for oral drug delivery
- (2008) Kathryn Whitehead et al. JOURNAL OF CONTROLLED RELEASE
- Complexation hydrogels for intestinal delivery of interferon β and calcitonin
- (2008) Noriyasu Kamei et al. JOURNAL OF CONTROLLED RELEASE
- Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
- (2008) Daniel J Drucker et al. LANCET
- Mechanistic Analysis of Chemical Permeation Enhancers for Oral Drug Delivery
- (2008) Kathryn Whitehead et al. PHARMACEUTICAL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now